top of page
The Professional Network for Healthcare Experts
Atavistik Bio and Roche sign allosteric drug discovery collaboration worth up to $1.9bn
The collaboration gives Roche access to Atavistik Bio's AMPS platform to discover allosteric small molecules across cardiovascular, renal and metabolic disease targets.
nuaxia
5 days ago1 min read
Sun Pharma licenses global rights to LIB Therapeutics' cholesterol drug lerodalcibep
The agreement gives Sun Pharma rights to the once-monthly PCSK9 inhibitor lerodalcibep across global markets excluding the US and China.
nuaxia
5 days ago1 min read
FDA approves Lerochol autoinjector and updates indication for monthly PCSK9 therapy
The new device provides adults with hypercholesterolaemia with an additional self-administration option for once-monthly Lerochol alongside the existing pre-filled syringe.
nuaxia
Aug 192 min read
bottom of page